HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Lü, F.X. Articles by Jacobson, R.S. Search for Related Content PubMed PubMed Citation Articles by Lü, F.X. Articles by Jacobson, R.S.

Oral Mucosal Immunity and HIV/SIV Infection

¹ California National Primate Research Center and Center for Comparative Medicine, University of California Davis, Davis, CA 95616, USA; and
² Greer Laboratories Inc., 639 Nuway Circle, PO Box 800, Lenoir, NC 28645, USA

^* corresponding author, fblu{at}greerlabs.com

Human Immunodeficiency Virus (HIV) transmission through genital and rectal mucosa has led to intensive study of mucosal immune responses to HIV and to the development of a vaccine administered locally. However, HIV transmission through the oral mucosa is a rare event. The oral mucosa represents a physical barrier and contains immunological elements to prevent the invasion of pathogenic organisms. This particular defense differs between micro-compartments represented by the salivary glands, oral mucosa, and palatine tonsils. Secretory immunity of the salivary glands, unique features of cellular structure in the oral mucosa and palatine tonsils, the high rate of oral blood flow, and innate factors in saliva may all contribute to the resistance to HIV/Simian Immunodeficiency Virus (SIV) oral mucosal infection. In the early stage of HIV infection, humoral and cellular immunity and innate immune functions in oral mucosa are maintained. However, these particular immune responses may all be impaired as a result of chronic HIV infection. A better understanding of oral mucosal immune mechanisms should lead to improved prevention of viral and bacterial infections, particularly in immunocompromised persons with Acquired Immune Deficiency Syndrome (AIDS), and to the development of a novel strategy for a mucosal AIDS vaccine, as well as vaccines to combat other oral diseases, such as dental caries and periodontal diseases.

KEY WORDS: oral mucosa • saliva • salivary glands • palatine tonsil • HIV/SIV

This article has been cited by other articles:

				C. Dawes Salivary flow patterns and the health of hard and soft oral tissues J Am Dent Assoc, May 1, 2008; 139(suppl_2): 18S - 24S. [Abstract] [Full Text] [PDF]